Review
Published on 13 Jul 2023
Epigenetics in myeloproliferative neoplasms
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1206965
- 5,686 views
- 7 citations
Type at least 3 characters
2,053 articles
articles
Original Research
Published on 05 Jul 2023
Profiling of miRNAs and their interfering targets in peripheral blood mononuclear cells from patients with chronic myeloid leukaemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1173970
- 3,595 views
- 3 citations
Original Research
Published on 04 Jul 2023
Mitochondrial apoptosis-related gene polymorphisms are associated with responses to anthracycline-based chemotherapy in acute myeloid leukaemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1179937
- 3,134 views
- 1 citation
Mini Review
Published on 03 Jul 2023
New treatment options in elderly patients with Diffuse Large B-cell Lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1214026
- 17,399 views
- 15 citations
Case Report
Published on 28 Jun 2023
Case report: biallelic DNMT3A mutations in acute myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1205220
- 3,519 views
- 1 citation
Editorial
Published on 27 Jun 2023
Editorial: Acute promyelocytic leukemia - towards a chemotherapy-free approach to cure in all patients, Volume II
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1238486
- 2,153 views
Review
Published on 27 Jun 2023
Unveiling the complexity of transcription factor networks in hematopoietic stem cells: implications for cell therapy and hematological malignancies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1151343
- 6,207 views
- 9 citations
Original Research
Published on 23 Jun 2023
Characterization and outcome of post-transplant lymphoproliferative disorders within a collaborative study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1208028
- 3,715 views
- 5 citations
Original Research
Published on 23 Jun 2023
The prognostic index PRIMA-PI combined with Ki67 as a better predictor of progression of disease within 24 months in follicular lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1090610
- 3,956 views
- 6 citations
Review
Published on 23 Jun 2023
How molecular advances may improve the diagnosis and management of PTCL patients
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1202964
- 6,161 views
- 3 citations
Brief Research Report
Published on 22 Jun 2023
Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1212752
- 3,440 views
- 10 citations
Editorial
Published on 19 Jun 2023
Editorial: Deciphering the bone marrow microenvironment in hematologic malignancies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1231467
- 1,826 views
- 1 citation
Editorial
Published on 16 Jun 2023
Editorial: T-cell directed therapies in multiple myeloma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1206475
- 2,155 views
- 3 citations
Original Research
Published on 16 Jun 2023
Therapy of childhood acute lymphoblastic leukemia in resource-poor geospaces
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1187268
- 2,862 views
- 2 citations
Case Report
Published on 15 Jun 2023
Case Report: Severe cutaneous adverse event associated with checkpoint inhibition in the setting of CAR T-cell therapy: beyond CRS
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1171031
- 3,632 views
- 7 citations
Original Research
Published on 13 Jun 2023
Clonal evolution in tyrosine kinase inhibitor-resistance: lessons from in vitro-models
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1200897
- 4,372 views
- 11 citations
Systematic Review
Published on 13 Jun 2023
Efficacy and safety of histone deacetylase inhibitors in peripheral T-cell lymphoma: a systematic review and meta-analysis on prospective clinical trials
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1127112
- 5,294 views
- 7 citations
Original Research
Published on 13 Jun 2023
Metabolic bulk volume predicts survival in a homogeneous cohort of stage II/III diffuse large B-cell lymphoma patients undergoing R-CHOP treatment
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1186311
- 2,695 views
- 6 citations
Review
Published on 12 Jun 2023
Transcription factor genetics and biology in predisposition to bone marrow failure and hematological malignancy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1183318
- 6,179 views
- 4 citations
Original Research
Published on 09 Jun 2023
Dyslipidemia in diffuse large B-cell lymphoma based on the genetic subtypes: a single-center study of 259 Chinese patients
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1172623
- 3,432 views
- 3 citations
Review
Published on 09 Jun 2023
Myeloproliferative neoplasms – blurring the lines between cancer and chronic inflammatory disorder
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1208089
- 12,034 views
- 12 citations
Editorial
Published on 09 Jun 2023
Editorial: Real-world data and real-world evidence in hematologic malignancies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1232980
- 2,441 views
Case Report
Published on 08 Jun 2023
Case Report: Effects of multiple myeloma therapy on essential thrombocythemia and vice versa: a case of synchronous dual hematological malignancy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1213942
- 3,674 views
- 3 citations
Original Research
Published on 08 Jun 2023
Development and validation of platelet-to-albumin ratio as a clinical predictor for diffuse large B-cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1138284
- 3,665 views
- 7 citations